Dexcom Shares Rise After FDA Panel Vote - Wall Street Journal

Mass Device

Dexcom Shares Rise After FDA Panel Vote Wall Street Journal DexCom Inc. DXCM 3.10 % shares rose Friday after a U.S. Food and Drug Administration panel voted in favor of the company's proposed non-adjunctive indication for a glucose-monitoring system. The DexCom G5 continuous glucose-monitoring system ... FDA Advisory Committee Votes in Favor of Non-Adjunctive Label for DexCom G5 Mobile CGM SystemPR Newswire (press release) FDA Panel Says Yes to Expanded CGM UseMedPage Today FDA Panel Supports Using CGM for Insulin DosingAJMC.com Managed Markets Network Managed Care magazine -Mass Device -Digital Journal -WhaTech all 12 news articles »

from Health - Google News http://news.google.com/news/url?sa=t&fd=R&ct2=us&usg=AFQjCNG7ZAZ7Aw8JrBVIXFyb3txjYHVgQg&clid=c3a7d30bb8a4878e06b80cf16b898331&cid=52779164539650&ei=myiSV9CMAcbH3gHYlpe4Bg&url=http://www.wsj.com/articles/dexcom-shares-rise-after-fda-panel-vote-1469195302
via IFTTT